Clinical Trial Update: Alisporivir With RBV in Chronic Hepatitis C Genotype 2 and 3 Participants for Whom Interferon is Not an Option [Phase 2]

View source ↗

Summary

Phase 2 trial of alisporivir with ribavirin in chronic hepatitis C genotypes 2 and 3 patients who cannot take interferon; the study completed and results were p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Liver Disease

Drugs mentioned

• Alisporivir (alisporivir)
• Ribavirin (ribavirin)

Snippet

Sponsor: Debiopharm International SA | Conditions: Hepatitis C, Liver Disease | Phase 2 | Status: COMPLETED | Results posted: 2016-10-13